NARA Discovery
Article Details
← Back to Search Results
Journal Article

A transgenic mouse line for assaying tissue-specific changes in endoplasmic reticulum proteostasis

Reinis Svarcbahs; Sarah M. Blossom; Helena S. Baffoe-Bonnie; Kathleen A. Trychta; Lacey K. Greer; James Pickel; Mark J. Henderson; Brandon K. Harvey
Transgenic Research · Vol. 32, Issue 3 · pp. 209-221 · 2023

Abstract

Maintenance of calcium homeostasis is important for proper endoplasmic reticulum (ER) function. When cellular stress conditions deplete the high concentration of calcium in the ER, ER-resident proteins are secreted into the extracellular space in a process called exodosis. Monitoring exodosis provides insight into changes in ER homeostasis and proteostasis resulting from cellular stress associated with ER calcium dysregulation. To monitor cell-type specific exodosis in the intact animal, we created a transgenic mouse line with a Gaussia luciferase (GLuc)—based, secreted ER calcium-modulated protein, SERCaMP, preceded by a LoxP-STOP-LoxP (LSL) sequence. The Cre-dependent LSL-SERCaMP mice were crossed with albumin (Alb)-Cre and dopamine transporter (DAT)-Cre mouse lines. GLuc-SERCaMP expression was characterized in mouse organs and extracellular fluids, and the secretion of GLuc-SERCaMP in response to cellular stress was monitored following pharmacological depletion of ER calcium. In LSL-SERCaMP × Alb-Cre mice, robust GLuc activity was observed only in the liver and blood, whereas in LSL-SERCaMP × DAT-Cre mice, GLuc activity was seen in midbrain dopaminergic neurons and tissue samples innervated by dopaminergic projections. After calcium depletion, we saw increased GLuc signal in the plasma and cerebrospinal fluid collected from the Alb-Cre and DAT-Cre crosses, respectively. This mouse model can be used to investigate the secretion of ER-resident proteins from specific cell and tissue types during disease pathogenesis and may aid in the identification of therapeutics and biomarkers of disease.

Bibliographic Information

JournalTransgenic Research
PublisherSpringer
Publication Date2023-06-01
Publication Year2023
Volume32
Issue3
Pages209-221
Document TypeJournal Article
eISSN1573-9368
DOI10.1007/s11248-023-00349-7

Access Information

NARA Access Coverage1991-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11248
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.